5th Circ. Frees Pliva, Others From Generic Reglan Claims
The Fifth Circuit affirmed Thursday that a couple suing Pliva Inc., Watson Pharmaceuticals Inc. and other manufacturers of generic medicines failed to show that the companies caused their son's birth defects...To view the full article, register now.
Already a subscriber? Click here to view full article